Ubright Optronics Corporation (TPEX:4933)

Market Cap	5.16B
Revenue (ttm)	3.07B
Net Income (ttm)	603.91M
Shares Out	81.93M
EPS (ttm)	7.34
PE Ratio	8.58
Forward PE	n/a
Dividend	6.00 (9.57%)
Ex-Dividend Date	Jul 22, 2025

Volume	2,000
Average Volume	816,218
Open	63.00
Previous Close	63.00
Day's Range	62.80 - 64.90
52-Week Range	61.00 - 86.20
Beta	0.38
RSI	23.22
Earnings Date	Aug 12, 2025

About Theseus Pharmaceuticals

Ubright Optronics Corporation engages in the manufacture and sale of optical films in Taiwan. It offers prism, multi function, and quantum dot films for backlight displays; polarizer protection and anti-glare films for LCD displays; 3D curve display protection films for OLED displays; anti-static protection, in process panel protection, hard coat, masking protection, and optical clear adhesive films for touch panels; anti-glare films for E paper products; and ceramic window films for windows. The company is also involved in wholesale of molds. ...

• Industry: Electronic Components
• Sector: Technology
• Founded: 2003
• Employees: 484
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4933

Financial Performance

In 2024, Ubright Optronics's revenue was 2.94 billion, an increase of 17.55% compared to the previous year's 2.50 billion. Earnings were 575.59 million, an increase of 69.52%.